ELUT GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
ELUT
Elutia Inc - Class A
Exchange: NASDAQSector: HealthcareIndustry: Medical Devices
Aziyo Biologics Inc - Class A
Did you know?
Price sits at 26% of its 52-week range.
Current Price
$1.01
-0.98%Profile
Valuation (TTM)
Market Cap$43.13M
P/E0.81
EV—
P/B1.56
Shares Out42.70M
P/Sales2.28
Revenue$18.89M
EV/EBITDA0.31
Elutia Inc - Class A (ELUT) Quality Analysis
ELUT Profitability
Profitability trend analysis coming soon
ELUT Growth
Growth trend analysis coming soon
ELUT Financial Health
Financial health indicators coming soon
ELUT Quality & Fundamental Analysis
Elutia Inc - Class A (ELUT) is a Healthcare company in the Medical Devices industry, listed on NASDAQ. This quality analysis page evaluates Elutia Inc - Class A's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Elutia Inc - Class A has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 282.63% and a return on equity (ROE) of 192.90%. Return on assets (ROA) stands at 85.61%.
The debt-to-equity ratio is 0.40, with a current ratio of 2.22. Operating margin is -218.91%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Elutia Inc - Class A is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.